ESTRO 2024 - Abstract Book

S5667

RTT - Patient experience and quality of life

ESTRO 2024

A pilot simulator sickness questionnaire was adopted and administered to 13 healthy volunteers (2 children and 11 adults). No one reported headache, eye strain, difficulty in focusing, nausea or vertigo after the VR experience. Three respondents experienced mild fullness of the head based on the 4-point Likert scale. Overall, VR patient education was well received, and have been implemented clinically. The VR application has the potential to reduce anxiety and shorten the time of CT simulation and potentially avoid the need for general anesthesia. In terms of scalability, VR modules for other procedures can be produced. This will enhance patient education experience for paediatric patients, who often require more time due to understanding of the clinical procedure. In addition, improved consistency of patient briefing will in turn free up clinical staff to prepare peripheral workflows.

Conclusion:

A 360-VR patient education module for CT simulation has been successfully developed and implemented for future paediatric cases.

Keywords: VR, patient education

References:

[1] Kennedy, R.S., Lane, N.E., Berbaum, K.S., & Mg, L. (1993). Simulator Sickness Questionnaire: An enhanced method for quantifying simulator sickness. The International Journal of Aviation Psychology, 3, 203-220

1216

Digital Poster

Person-centred through an LGBTIQ+ lens

Stewart O'Callaghan 1 , Joanna McNamara 2 , Naman Julka-Anderson 2

1 OUTpatients, Charity, London, United Kingdom. 2 Rad Chat, Podcast, Sheffield, United Kingdom

Purpose/Objective:

LGBTIQ+ patients face numerous inequalities throughout the cancer pathway including systemic barriers to screening, patient experience differences, and deficits in knowledge from insufficient training. To address this, LGBTIQ+ patients may require additional support to access equitable care. The LGBTIQ+ community has a higher prevalence of cancer risk factors, such as smoking, drinking, and viral infections such as HPV and HIV. Of the four most common cancers, UK biobank data confirms an increased incidence of lung cancer in LGB people, whilst the American National Health Interview Survey 2017-2014 shows a higher prevalence of self-reported rare and less common cancers including gynae, skin, leukaemia, bone, bladder and others. Gender affirming care can also modulate cancer risk, in some cases reducing potential for oncogenesis and in other cases potentially increasing risk.